| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |